Alpha Pro Tech APT – Swine Flu Stocks to Watch
Alpha Pro Tech Swine Flu – N95 Mask (AMEX: APT)
Alpha Pro Tech (APT) is linked to the influenza virus and strains like the new H1N1 virus through products including protective apparel, infection control, building products, and pet supplies.
With top pharmaceutical and biotech companies like AVI Biopharma (AVII), GlaxoSmithKline (GSK), AstraZeneca (AZN), and Roche (SW: RO) currently trialling swine flu vaccines, flu antiviral treatments and other pharmaceuticals, Alpha Pro Tech (APT) is providing products including face masks, coveralls, caps and coats.
The company serves a high value market for top pharmaceutical companies and the biotech industry top players like Roche (SW: RO), GlaxoSmithKline (GSK) and Baxter International Inc (BAX) as well as government health organisations (WHO) and medical device manufacturing companies.
One of their innovative and top selling products, the PFL N95 mask, currently meets both WHO and CDC protection levels in order to project individuals from the spreads of the influenza virus from those already suffering the swine flu symptoms.
Formed in 1999, and with 4 manufacturing facilities in the US, Alpha Pro Tech has a key growth strategy based on communicating directly with end users to develop innovative products to suit their needs.